As part of large-scale clinical studies prior to market introduction, the AI software has now gone into clinical test with patients, so-called first-in-human applications
As an industrial partner of the IHU, the Medi-Globe Group is thus further expanding its role as an innovation leader in minimally invasive diagnostics and therapies
Dr. Matthew Weiss presents data on patient organoids & cancer care at the American Surgical Association annual meeting
The company also reported the issuance of an additional U.S. patent covering the drug, and the filing of a continuation patent application intended to expand patent coverage to other facets of the drug
The dedicated HPB and liver transplant centre will be headed by Dr. Vivek Vij, Chairman -Advanced Surgical GI, HPB & Liver Transplant and his team of experts
The modular platform not only targets solid tumors but could also enhance traditional autologous and in vivo T cell therapies
Olaparib is indicated for the treatment of certain types of ovarian, breast, pancreatic, and prostate cancers
Takeda will make an upfront payment of $1.2 billion, which includes a $100 million equity investment in Innovent
First patients enrolled in Phase I trial with KQB548, an investigational KRAS inhibitor designed to treat KRAS G12D-mutated tumors
Subscribe To Our Newsletter & Stay Updated
